Drug Trial Radar · NCT07652697
ABX-002 Bioequivalence and Effect of Food Study in Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: Jun 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
18
Actual
Start
Jan 2, 2025
Primary completion
Feb 17, 2025
Study completion Feb 17, 2025
Sponsor
- Lead sponsor
- Autobahn Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 19 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this study is to assess the bioequivalence (BE) between the liquid formulation and the new solid formulation of ABX-002 under fasting conditions and to evaluate the effect of food on the pharmacokinetics (PK) of the new solid formulation of ABX-002.This study design is consistent with FDA guidelines for the assessment of BE. This was an open label, randomized, single dose, three-way crossover BE and food-effect study. Therefore, the total number of participants in this study was 18.
Conditions
- Healthy
Interventions
ABX-002Drug
ABX-002 was supplied as a solution and solid dose form.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate the bioequivalence between ABX-002 liquid formulation and ABX-002 solid formulation in healthy adult participants.Time frame: 8 weeks
- Evaluate the bioequivalence between ABX-002 liquid formulation and ABX-002 solid formulationTime frame: 8 weeks
- Evaluate the bioequivalence between ABX-002 liquid formulation and ABX-002 solid formulationTime frame: 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion
Lincoln, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.